deltatrials
Completed PHASE3 NCT00765700

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study to Assess the Efficacy and Safety of Ketotransdel™ (Ketoprofen Topical Cream 10%) in the Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury.

Sponsor: Cato Research

Conditions Acute Soft Tissue Injury Sprain Strain
Interventions Topical Ketoprofen 10% Cream Topical Placebo Cream
Updated 7 times since 2017 Last updated: Sep 20, 2013 Started: Sep 30, 2008 Primary completion: Aug 31, 2009 Completion: Sep 30, 2009

A PHASE3 clinical study on Acute Soft Tissue Injury and Sprain, this trial is completed. The trial is conducted by Cato Research and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Apr 2022 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cato Research
  • Imprimis Pharmaceuticals, Inc.
Data source: Imprimis Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Durham, United States